CRH Medical Corporation provides anesthesia services for patients undergoing endoscopic procedures in the United States and Canada. More Details
Reasonable growth potential and slightly overvalued.
Share Price & News
How has CRH Medical's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: CRH is more volatile than 90% of Canadian stocks over the past 3 months, typically moving +/- 23% a week.
Volatility Over Time: CRH's weekly volatility has increased from 14% to 23% over the past year.
7 Day Return
1 Year Return
Return vs Industry: CRH exceeded the Canadian Healthcare industry which returned 46.1% over the past year.
Return vs Market: CRH exceeded the Canadian Market which returned 39.7% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is CRH Medical's share price compared to the market and industry in the last 5 years?
Simply Wall St News
3 weeks ago | Simply Wall StHave Insiders Been Selling CRH Medical Corporation (TSE:CRH) Shares?
1 month ago | Simply Wall StWould CRH Medical (TSE:CRH) Be Better Off With Less Debt?
3 months ago | Simply Wall StShould CRH Medical (TSE:CRH) Be Disappointed With Their 42% Profit?
Is CRH Medical undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: CRH (CA$4.97) is trading below our estimate of fair value (CA$11.54)
Significantly Below Fair Value: CRH is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: CRH is unprofitable, so we can't compare its PE Ratio to the CA Healthcare industry average.
PE vs Market: CRH is unprofitable, so we can't compare its PE Ratio to the Canadian market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate CRH's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: CRH is overvalued based on its PB Ratio (5.3x) compared to the CA Healthcare industry average (4.9x).
How is CRH Medical forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CRH is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.5%).
Earnings vs Market: CRH is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: CRH's is expected to become profitable in the next 3 years.
Revenue vs Market: CRH's revenue (10.6% per year) is forecast to grow faster than the Canadian market (7.6% per year).
High Growth Revenue: CRH's revenue (10.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if CRH's Return on Equity is forecast to be high in 3 years time
How has CRH Medical performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: CRH is currently unprofitable.
Growing Profit Margin: CRH is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: CRH is unprofitable, and losses have increased over the past 5 years at a rate of 39.4% per year.
Accelerating Growth: Unable to compare CRH's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: CRH is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (106.9%).
Return on Equity
High ROE: CRH has a negative Return on Equity (-21.63%), as it is currently unprofitable.
How is CRH Medical's financial position?
Financial Position Analysis
Short Term Liabilities: CRH's short term assets ($31.5M) exceed its short term liabilities ($11.8M).
Long Term Liabilities: CRH's short term assets ($31.5M) do not cover its long term liabilities ($74.1M).
Debt to Equity History and Analysis
Debt Level: CRH's debt to equity ratio (66.8%) is considered high.
Reducing Debt: CRH's debt to equity ratio has increased from 54.4% to 66.8% over the past 5 years.
Debt Coverage: CRH's debt is well covered by operating cash flow (50.9%).
Interest Coverage: Insufficient data to determine if CRH's interest payments on its debt are well covered by EBIT.
What is CRH Medical current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate CRH's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate CRH's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if CRH's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if CRH's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of CRH's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Tushar Ramani (55 yo)
Dr. Tushar M. Ramani, MD has been Chief Executive Officer of CRH Medical Corporation since April 8, 2019 and has been its Chairman since March 19, 2020 and Director since April 9, 2019. Dr. Ramani is a vet...
CEO Compensation Analysis
Compensation vs Market: Tushar's total compensation ($USD1.07M) is above average for companies of similar size in the Canadian market ($USD452.92K).
Compensation vs Earnings: Tushar's compensation has been consistent with company performance over the past year.
Experienced Management: CRH's management team is considered experienced (4.8 years average tenure).
Experienced Board: CRH's board of directors are not considered experienced ( 1.1 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
CRH Medical Corporation's company bio, employee growth, exchange listings and data sources
- Name: CRH Medical Corporation
- Ticker: CRH
- Exchange: TSX
- Founded: 2000
- Industry: Health Care Services
- Sector: Healthcare
- Market Cap: CA$360.609m
- Shares outstanding: 71.62m
- Website: https://www.crhmedcorp.com
Number of Employees
- CRH Medical Corporation
- World Trade Center
- Suite 619
- British Columbia
- V6C 3E1
CRH Medical Corporation provides anesthesia services for patients undergoing endoscopic procedures in the United States and Canada. It offers CRH O’Regan system, a single use, disposable, and hemorrhoid ba...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/04/22 07:18|
|End of Day Share Price||2021/04/21 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.